Burford Capital Ltd

Rule 10b5-1 trading arrangements

On August 28, 2025, Mr. Christopher Bogart, our Chief Executive Officer, as trustee of, and on behalf of, Christopher P. Bogart Revocable Trust, entered into a “Rule 10b5-1 trading arrangement” (as defined by Item 408(a) of Regulation S-K). Mr. Bogart’s “Rule 10b5-1 trading arrangement” provides for the sale of up to 375,000 of the Company’s ordinary shares between December 2, 2025 and September 30, 2026 and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.

On August 28, 2025, Mr. Jonathan Molot, our Chief Investment Officer, entered into a “Rule 10b5-1 trading arrangement” (as defined by Item 408(a) of Regulation S-K). Mr. Molot’s “Rule 10b5-1 trading arrangement” provides for the sale of up to 375,000 of the Company’s ordinary shares between December 2, 2025 and September 30, 2026 and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.

On August 28, 2025, Ms. Elizabeth O’Connell, our Chief Strategy Officer, as trustee of, and on behalf of, Elizabeth O’Connell Revocable Trust, entered into a “Rule 10b5-1 trading arrangement” (as defined by Item 408(a) of Regulation S-K). Ms. O’Connell’s “Rule 10b5-1 trading arrangement” provides for the sale of up to 20,000 of the Company’s ordinary shares between December 2, 2025 and September 30, 2026 and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.

On September 2, 2025, Ms. Aviva Will, our President, entered into a “Rule 10b5-1 trading arrangement” (as defined by Item 408(a) of Regulation S-K). Ms. Will’s “Rule 10b5-1 trading arrangement” provides for the sale of up to 30,000 of the Company’s ordinary shares between December 2, 2025 and September 30, 2026 and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.

On September 2, 2025, Mr. David Perla, our Vice Chair, entered into a “Rule 10b5-1 trading arrangement” (as defined by Item 408(a) of Regulation S-K). Mr. Perla’s “Rule 10b5-1 trading arrangement” provides for the sale of up to 30,000 of the Company’s ordinary shares between December 2, 2025 and September 30, 2026 and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.

Except as set forth above, no other “Rule 10b5-1 trading arrangements” or “non-Rule 10b5-1 trading arrangements” (each, as defined by Item 408(a) and Item 408(c), respectively, of Regulation S-K) were adopted, modified orterminated by our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) during the three months ended September 30, 2025.